Chennai Meenakshi Multispeciality Hospital Ltd

Chennai Meenakshi Multispeciality Hospital Ltd., a 105-bed healthcare facility in Chennai's Mylapore area, reported a marginal return to losses in Q4 FY26 with a net loss of ₹0.02 crores, reversing from a profit of ₹0.31 crores in the year-ago quarter. The micro-cap hospital operator, with a market capitalisation of ₹30.00 crores, saw its stock surge 4.35% to ₹41.22 following the results announcement, though this price movement appears disconnected from the underlying financial deterioration that continues to plague the company.

Chennai Meenakshi Multispeciality Hospital Ltd has been downgraded from a Sell to a Strong Sell rating as of 18 May 2026, reflecting deteriorating technical indicators and persistent financial weaknesses. Despite some market-beating returns over the past year, the company’s micro-cap status, negative book value, and flat recent financial performance have raised significant concerns among analysts.

Chennai Meenakshi Multispeciality Hospital Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by a shift in technical indicators despite ongoing fundamental challenges. The healthcare services micro-cap’s technical trend has improved to mildly bullish, prompting a reassessment of its outlook, although valuation and financial trends remain subdued.

Chennai Meenakshi Multispeciality Hospital Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 27 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Chennai Meenakshi Multispeciality Hospital Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 27 February 2026, reflecting a marked deterioration in its technical indicators alongside stagnant financial performance and challenging valuation metrics. The healthcare services company’s Mojo Score has declined to 17.0, signalling heightened risk for investors amid a mildly bearish technical outlook and weak fundamental trends.

Chennai Meenakshi Multispeciality Hospital Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 23 February 2026, driven primarily by a shift in technical indicators despite ongoing challenges in financial performance. The healthcare services company’s Mojo Score rose to 33.0, reflecting a cautious but improved outlook amid mixed signals from valuation and financial trends.

Chennai Meenakshi Multispeciality Hospital Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 16 Feb 2026, reflecting deteriorating technical indicators and persistent fundamental weaknesses. The healthcare services company’s Mojo Score fell to 23.0, signalling heightened risk for investors amid sideways technical trends and flat financial performance.

Chennai Meenakshi Multispeciality Hospital Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by a shift in technical indicators despite ongoing fundamental challenges. The company’s technical trend has improved from mildly bearish to mildly bullish, prompting a reassessment of its outlook. However, financial performance remains flat, and valuation concerns persist, underscoring a cautious stance for investors.

Chennai Meenakshi Multispeciality Hospital Ltd., a micro-cap healthcare services provider operating a 100-bed facility in Chennai's Mylapore locality, returned to profitability in Q2 FY26 with a net profit of ₹0.15 crores, reversing the ₹0.74 crores loss posted in the previous quarter. However, the achievement masks deeper structural concerns about the company's financial viability, with negative book value of ₹1.89 crores and a troubling history of inconsistent profitability that continues to weigh on investor sentiment.

Chennai Meenakshi Multispeciality Hospital Ltd has been downgraded from a Sell to a Strong Sell rating as of 6 February 2026, reflecting deteriorating technical indicators and stagnant financial performance. The healthcare services company’s Mojo Score has declined to 17.0, signalling heightened risk for investors amid a challenging market environment and weak fundamentals.

Chennai Meenakshi Multispeciality Hospital Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 1 February 2026, driven primarily by a shift in technical indicators despite persistent fundamental challenges. The healthcare services company’s Mojo Score improved to 33.0, reflecting a mildly bullish technical trend, although its long-term financial health and valuation metrics remain concerning for investors.

Chennai Meenakshi Multispeciality Hospital Ltd has been downgraded from a Sell to a Strong Sell rating as of 22 Jan 2026, reflecting deteriorating technical indicators and persistent fundamental weaknesses. Despite a modest day gain of 1.06% to ₹43.00, the stock continues to underperform the broader market and faces significant challenges across quality, valuation, financial trends, and technical parameters.

Chennai Meenakshi Multispeciality Hospital Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 Oct 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 26 December 2025, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.